Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R03)

archived

The purpose of this funding opportunity announcement (FOA) is to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. This FOA also encourages the development of novel drug delivery systems in the pediatric population. Investigators are encouraged to explore approaches and concepts new to the area of pediatric formulation development and testing and use newly developed techniques superior to the ones currently used in the field. This FOA supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding.

High